Skip to content

Examination of the impact of PF on daily discomfort and work productivity in healthy adult employee: A randomized, double-blind , placebo-controlled, cross-over study.

Examination of the impact of PF on daily discomfort and work productivity in healthy adult employee: A randomized, double-blind , placebo-controlled, cross-over study. - The efficacy of the test food on daily discomfort and work productivity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029230
Enrollment
44
Registered
2018-12-15
Start date
2017-09-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Intake of test food for a week, then int ake of placebo for a week after 3-wee k wash out period. Intake of placebo for a week, then inta ke of test food for a week after 3-wee k wash out period.

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) healthy workers between 20-65 years of age 2) subjects who are off on weekends 3) subjects who recognize daily discomfort

Exclusion criteria

Exclusion criteria: 1) subjects who have allergy to medicinal and foods. 2) subjects who have a severe past medical history, acute infection, or mental disorder. 3) subjects who will have stressful situation in the intake periods. 4) subjects who smoke more than 20 cigarettes a day. 5) subjects who take alcohol nearly every day. 6) subjects who take much caffeine rich drink. 7) shift wokers and graveyard shift. 8) subjects who routinely take medicin, supplements, FOSHU, and/or healt h food which affect to the result of the study. 9) subjects who are estimated inappropriate to participate to this study by principal investigator.

Design outcomes

Primary

MeasureTime frame
QOL index, Work productivity, Fatigue index, Daily discomfort

Countries

Japan

Contacts

Public ContactYoshika Komori

KSO Corporation Sales department

yoshikawa@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026